Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.45B |
| 2 |
NextEra Energy
NEE
|
+$1.44B |
| 3 |
RTX Corp
RTX
|
+$1.37B |
| 4 |
Air Products & Chemicals
APD
|
+$1.19B |
| 5 |
Microsoft
MSFT
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$2.41B |
| 2 |
Netflix
NFLX
|
+$1.67B |
| 3 |
Comcast
CMCSA
|
+$1.51B |
| 4 |
Baker Hughes
BKR
|
+$1.21B |
| 5 |
Cenovus Energy
CVE
|
+$1.14B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.31% |
| 2 | Healthcare | 16.23% |
| 3 | Industrials | 12.73% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Financials | 8.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Kenvue
KVUE
$36.8B
| $46M | 0.01% |
2,135,609
-21
| -0% | -$420 |
|
327
Helmerich & Payne
HP
$4.31B
| $45.1M | 0.01% |
1,245,268
| – | – |
|
328
On Holding
ONON
$10.2B
| $44.6M | 0.01% |
1,654,871
-325,739
| -16% | -$8.87M |
|
329
BridgeBio Pharma
BBIO
$16.2B
| $44.4M | 0.01% |
1,100,110
| – | – |
|
330
IHS Holding
IHS
$2.82B
| $43.8M | 0.01% |
9,515,835
+2,105,869
| +28% | +$10.4M |
|
331
RH
RH
$3.47B
| $43.7M | 0.01% |
150,000
| – | – |
|
332
Pfizer
PFE
$152B
| $43.4M | 0.01% |
1,505,865
-183
| -0% | -$5.53K |
|
333
Camping World
CWH
$671M
| $43.2M | 0.01% |
1,645,717
| – | – |
|
|
AZPN
334
DELISTED
Aspen Technology Inc
AZPN
| $42.3M | 0.01% |
192,192
| – | – |
|
335
Marqeta
MQ
$1.68B
| $41.4M | 0.01% |
1,483,319
-253,078
| -15% | -$6.06M |
|
336
Immunovant
IMVT
$8.78B
| $41.1M | 0.01% |
976,237
+226,237
| +30% | +$8.33M |
|
|
AVDX
337
DELISTED
AvidXchange
AVDX
| $41M | 0.01% |
3,310,635
| – | – |
|
338
APi Group
APG
$18.7B
| $40.3M | 0.01% |
+1,746,150
| New | +$33.7M |
|
339
Installed Building Products
IBP
$6.55B
| $39.9M | 0.01% |
218,259
| – | – |
|
340
MKS Inc
MKSI
$21.3B
| $39.8M | 0.01% |
387,153
| – | – |
|
341
Structure Therapeutics
GPCR
$3.81B
| $39.7M | 0.01% |
973,535
+628,687
| +182% | +$36M |
|
342
AT&T
T
$166B
| $39.2M | 0.01% |
2,335,287
| – | – |
|
343
Vista Energy
VIST
$7.32B
| $36.3M | 0.01% |
1,231,407
+802,252
| +187% | +$23.7M |
|
344
Bentley Systems
BSY
$10.6B
| $35.9M | 0.01% |
687,478
| – | – |
|
345
Cabot Corp
CBT
$4.45B
| $35.4M | 0.01% |
424,385
| – | – |
|
346
Globant
GLOB
$1.68B
| $34.9M | 0.01% |
146,564
| – | – |
|
347
Royal Bank of Canada
RY
$300B
| $34.5M | 0.01% |
+341,517
| New | +$30.1M |
|
348
Grupo Aeroportuario del Pacifico
PAC
$12.6B
| $30.6M | 0.01% |
174,630
| – | – |
|
|
CCC
349
CCC Intelligent Solutions
CCC
$4.07B
| $30.2M | 0.01% |
2,655,050
-1,419,842
| -35% | -$16.6M |
|
350
Alcon
ALC
$35.5B
| $29.3M | 0.01% |
374,347
+325,804
| +671% | +$24.1M |
|
Similar funds
Capital Research Global Investors's Q4 2023 Portfolio in Review
As of Q4 2023, Capital Research Global Investors held 429 positions worth $406B, up 12% from $363B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Capital Research Global Investors's Q4 2023 filing shows 19 new, 170 increased, 154 reduced and 21 closed positions. Its largest new stake was Sysco: 3,107,352 shares worth $227M. The largest sale was Starbucks, an estimated $2.41B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.
- Capital Research Global Investors's largest Q4 2023 buy was Sysco: 3,107,352 shares worth $227M.
- Capital Research Global Investors added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.45B increase.
- Capital Research Global Investors's biggest Q4 2023 reduction was Starbucks, cutting an estimated $2.41B.
- Capital Research Global Investors fully exited Cummins in Q4 2023, selling an estimated $504M.
- Capital Research Global Investors's ten largest holdings make up 30% of its $406B portfolio in Q4 2023.
- Capital Research Global Investors opened 19 new positions and closed 21 in Q4 2023.
- Capital Research Global Investors's portfolio value rose 12% quarter-over-quarter to $406B.
Based on Capital Research Global Investors's 13F filing for Q4 2023, filed 13 Feb 2024.